Active large-cap mutual-fund managers have bigger relative positions in financials such as Wells Fargo and BofA than big tech ...

Artificial intelligence will play an increasingly important role in preventing and treating diseases related to diabetes, ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...

The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...

When the doors close on the West Seventh Pharmacy on June 30, it will be for the final time. The pharmacy, in continuous ...

On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE: CI) with a price target of $390.

The discussion is almost at a final stage and the company will go to our board, and the board will take a call very soon, ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

The MD of the insurance broking firm also says that life insurance companies are likely to continue scaling back their ...